Skip to main content

F Squadrito

First name:
F
Last name:
Squadrito
Burnett, B. ., Pillai, L. ., Bitto, A. ., Squadrito, F. ., & Levy, R. . Evaluation of CYP450 inhibitory effects and steady-state pharmacokinetics of genistein in combination with cholecalciferol and citrated zinc bisglycinate in postmenopausal women. International Journal of women’s Health, 3, 139-50. https://doi.org/10.2147/IJWH.S19309 (Original work published 2011)
Burnett, B. ., Bitto, A. ., Altavilla, D. ., Squadrito, F. ., Levy, R. ., & Pillai, L. . Flavocoxid inhibits phospholipase A2, peroxidase moieties of the cyclooxygenases (COX), and 5-lipoxygenase, modifies COX-2 gene expression, and acts as an antioxidant. Mediators of Inflammation, 2011, 385780. https://doi.org/10.1155/2011/385780 (Original work published 2011)
Bitto, A. ., Bagnato, G. ., Pizzino, G. ., Roberts, W. ., Irrera, N. ., Minutoli, L. ., … Altavilla, D. . (2016). SIMVASTATIN PREVENTS VASCULAR COMPLICATIONS IN THE CHRONIC REACTIVE OXYGEN SPECIES MURINE MODEL OF SYSTEMIC SCLEROSIS. Free Radical Research, 1-28. https://doi.org/10.3109/10715762.2016.1149171 (Original work published 2016)
Bagnato, G. ., Irrera, N. ., Pizzino, G. ., Santoro, D. ., Roberts, W. ., Bagnato, G. ., … Bitto, A. . (2018). Dual αvβ3 and αvβ5 blockade attenuates fibrotic and vascular alterations in a murine model of systemic sclerosis. Clinical Science (London, England : 1979), 132(2), 231-242. https://doi.org/10.1042/CS20171426 (Original work published 2018)
Bagnato, G. ., Pigatto, E. ., Bitto, A. ., Pizzino, G. ., Irrera, N. ., Abignano, G. ., … Del Galdo, F. . The PREdictor of MAlnutrition in Systemic Sclerosis (PREMASS) Score: A Combined Index to Predict 12 Months Onset of Malnutrition in Systemic Sclerosis. Frontiers in Medicine, 8, 651748. https://doi.org/10.3389/fmed.2021.651748 (Original work published 2021)